Structure-function analysis of bcl-2 family proteins: Regulators of programmed cell death

Advances in Experimental Medicine and Biology

Volumn 406, Issue , 1996, Pages 99-112

  Reed, John C ^a   Zha, Hongbin ^a   Aime Sempe, Christine ^a   Takayama, Shinichi ^a   Wang, Hong Gang ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ARTICLE; CELL DEATH; DIMERIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION;

MAMMALIA; STAPHYLOCOCCUS PHAGE 187;

EID: 0029858891     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0274-0_10     Document Type: Article

References (86)

1. G.H. Fisher, F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Lin, W. Strober, M.J. Lenardo and J.M. Puck, Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell 81:935 (1995).
2. J.P. DiSanto, J.Y. Bonnefoy, J.F. Gauchat, A. Fischer and G. de Saint Basile, CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM, Nature 361:541 (1993).
3. R.C. Allen, R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, W.C. Fanslow, J. Belmont and M.K. Spriggs, CD40 ligand gene defects responsble for X-linked hyper-IgM syndrome, Science 259:990 (1993).
4. M.O. Westendorp, R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Waleczak, K.-M. Debatin and P.H. Krammer, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120, Nature 375:497 (1995).
5. T.H. Finkel and N.K. Banda, Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr. Opin. Immun. 6:605 (1994).
6. L. Meyaard, S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet and F. Miedema, Programmed death of T cells in HIV-1 infection, Science 257:217 (1992).
7. M.L. Gougeon, S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet and L. Montagnier, Programmed cell death in AIDS-related HIV and SIV infections, AIDS Res. Hum. Retroviruses 9:553 (1993).
8. G.T. Williams, Programmed cell death: apoptosis and oncogenesis, Cell 65:1097 (1991).
9. J.C. Reed, Bcl-2 and the regulation of programmed cell death, J. Cell Biol. 124:1 (1994).
10. S.J. Korsmeyer, Bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood 80:879 (1992).
11. D.L. Vaux, Toward an understanding of the molecular mechansisms of physiological cell death, Proc. Natl. Acad. Sci. USA 90:786 (1993).
12. Y. Tsujimoto, J. Cossman, E. Jaffe and C. Croce, Involvement of the bcl-2 gene in human follicular lymphoma, Science 228:1440 (1985).
13. Y. Tsujimoto and C.M. Croce, Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma, Proc. Natl. Acad. Sci. USA 83:5214 (1986).
14. D.L. Vaux, S. Cory and J.M. Adams, Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature 335:440 (1988).
15. D.M. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber and S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature 348:334 (1990).
16. J. Reed, S. Haldar, M. Cuddy, C. Croce and D. Makover, Bcl-2-mediated tumorigenicity in a T-lymphoid cell line: Synergy with C-MYC and inhibition by Bcl-2 antisense, Proc. Natl. Acad. Sci. USA 87:3660 (1990).
17. J. Reed, C. Stein, S. Haldar, C. Subasinghe, C. Croce, S. Yum and J. Cohen, Antisense-mediated inhibition of bcl-2 proto-oncogene expression and leukemic cell growth: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides, Cancer Res. 50:6565 (1990).
18. D.A.G. Galton and I.C.M. MacLennan, Clinical patterns of B cell malignancy, Clin. Hematol. 11:561 (1982).
19. Horning SJ and Rosenberg SA, The natural history of initially untreated low-grade non-Hodgkin's lymphomas, N. Eng. J. Med.. 311:1471 (1984).
20. M. Hanada, D. Delia, A. Aiello, E. Stadtmauer and J.C. Reed, bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia, Blood 82:1820 (1993).
21. L. Campos, J.-P. Roualult, O. Sabido, N. Roubi, C. Vasselon, E. Archimbaud, J.-P. Magaud and D. Guyotat, High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy, Blood 81:3091 (1993).
22. D. Campana, E. Coustan-Smith, A. Manabe, M. Buschle, S.C. Raimondi, F.G. Behm, R. Ashmun, M. Aricó, A. Biondi and C.-H. Pui, Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein, Blood 81:1025 (1993).
23. F. Pezzella, A.G.D. Tse, J.L. Cordell, K.A.F. Pulford, K.C. Gatter and D.Y. Mason, Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation, Am. J. Pathol. 137:225 (1990).
24. J.C. Reed, Bcl-2: Prevention of apoptosis as a mechanism of drug resistance, Hematology/Oncology Clinics of North America 9:451 (1995).
25. O. Hermine, C. Haioun, E. Lepage, M.-F. d'Agay, J. Briere, C. Lavignac, G. Fillet, G. Salles, J.-P. Marolleau, J. Diebold, F. Reyes and P. Gaulard, Prognostic significance of Bcl-2 protein expression in aggressive non-Hodgkin's Lymphoma, Blood 87:265 (1996).
26. K.-I. Nakayama, K. Nakayama, I. Negishi, K. Kuida, Y. Shinkai, M.C. Louie, L.E. Fields, P.J. Lucas, V. Stewart, F.W. Alt and D.Y. Loh, Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice, Science 261:1584 (1993).
27. D.J. Veis, C.M. Sorenson, J.R. Shutter and S.J. Korsmeyer, Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair, Cell 75:229 (1993).
28. A.N. Akbar, N. Borthwick, M. Salmon, W. Gombert, M. Bofill, N. Shamsadeen, D. Pilling, S. Pett, J.e. Grundy and G. Janossy, The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory, J. Exp. Med. 178:427 (1993).
29. F. Boudet, H. Lecoeur and M.-L. Gougeon, Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CDS+ T lymphocytes during HIV infection, J. Immunol. in press (1995).
30. K.M. Kozopas, T. Yang, H.L. Buchan, P. Zhou and R. Craig, Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2, Proc. Natl. Acad. Sci. USA 90:3516 (1993).
31. J.E. Reynolds, T. Yang, L. Qian, J.D. Jenkinson, P. Zhou, A. Eastman and R.W. Craig, Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells, Cancer Res. 54:6348 (1994).
32. Z. Oltvai, C. Milliman and S.J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74:609 (1993).
33. L.H. Boise, M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez and C.B. Thompson, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell 74:597 (1993).
34. E.Y. Lin, A. Orlofsky, M.S. Berger and M.B. Prystowsky, Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2, J. Immunol. 151:1979 (1993).
35. E.Y. Lin, A. Orlofsky, H.-G. Wang, J.C. Reed and M.B. Prystowsky, A1, a Bcl-2 family member prolongs cell survival and permits granulocyte differentiation, Blood 87:983 (1996).
36. S.S. Choi, I.-C. Park, J.W. Yun, Y.C. Sung, S. Hong and H. Shin, A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11:1693 (1995).
37. T. Chittenden, E.A. Harrington, R. O'Connor, C. Flemington, R.J. Lutz, G.I. Evan and B.C. Guild, Induction of apoptosis by the Bcl-2 homologue Bak, Nature 374:733 (1995).
38. M.C. Kiefer, M.J. Brauer, V.C. Powers, J.J. Wu, s.R. Ubansky, L.D. Tomei and P.J. Barr, Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak, Nature 374:736 (1995).
39. S.N. Farrow, J.H.M. White, I. Martinou, T. Raven, K.-T. Pun, C.J. Grinham, J.-C. Martinou and R. Brown, Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K, Nature 374:731 (1995).
40. G. Gillet, M. Guerin, A. Trembleau and G. Brun, A Bcl-2-related gene is activated in avian cells transformed by the Rous sarcoma virus, EMBO J. 14:1372 (1995).
41. L and Bcl-2, displaces box and promotes cell death, Cell 80:285 (1995).
42. J.M. Boyd, G.J. Gallo, B. Elangovan, A.B. Houghton, S. Malstrom, B.J. Avery, R.G. Ebb, T. Subramanian, T. Chittenden, R.J. Lutz and G. Chinnadurai, Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins, Oncogene 11:1921 (1995).
43. L. Rao, M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer and E. White, The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and bcl-2 proteins, Proc. Natl. Acad. Sci. USA 89:7742 (1992).
44. M.L. Cleary, S.D. Smith and J. Sklar, Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation, Cell 47:19 (1986).
45. J.G. Neilan, Z. Lu, C.L. Afonso, G.F. Kutish, M.D. sussman and D.L. Rock, An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1, J. Virol. 67:4391 (1993).
46. C.A. Smith, A novel viral homolgue of Bcl-2 and Ced-9, Trends Cell Biol. 5:344 (1995).
47. M.O. Hengartner and H.R. Horvitz, C. elegans cell survival gene ced-9 encodes a functional homolog of the mammlian proto-oncogene bcl-2, Cell 76:665 (1994).
48. T. Sato, M. Hanada, S. Bodrug, S. Irie, N. Iwama, L.H. Boise, C.B. Thompson, E. Golemis, L. Fong, H.-G. Wang and J.C. Reed, Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system, Proc. Natl. Acad. Sci. USA 91:9238 (1994).
49. S.E. Bodrug, C. Aimé-Sempé, T. Sato, S. Krajewski, M. Hanada and J.C. Reed, Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function, Cell Death Differ. 2:173 (1995).
50. T.W. Sedlak, Z.N. Oltvai, E. Yang, K. Wang, L.H. Boise, C.B. Thompson and S.J. Korsmeyer, Multiple Bcl-2 family members demonstrate selective dimerizations with Bax, Proc. Natl. Acad. Sci. USA 92:7834 (1995).
51. S. Krajewski, S. Bodrug, R. Gascoyne, K. Berean, M. Krajewska and J.C. Reed, Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes, Amer. J. Pathol. 145:515 (1994).
52. S. Krajewski, M. Krajewska, A. Shabaik, H.-G. Wang, S. Irie, L. Fong and J.C. Reed, Immunohistochemical analysis of in vivo patterns of Bcl-X expression, Cancer Res. 54:5501 (1994).
53. N. Motoyama, F. Wang, K.A. Roth, H. Sawa, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii and D.Y. Loh, Massive cell death of immature hematopoietic cells and neurons in Bcl-X-deficient mice, Science 267:1506 (1995).
54. C.M. Knudson, K.S.K. Tung, W.G. Tourtellotte, G.A.J. Brown and S.J. Korsmeyer, Bax-deficient mice with lymphoid hyperplasia and male germ cell death, Science 270:96 (1995).
55. S. Krajewski, S. Tanaka, S. Takayama, M.J. Schibler, W. Fenton and J.C. Reed, Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701 (1993).
56. M.D. Jacobson, J.F. Burne, M.P. King, T. Miyashita, J.C. Reed and M.C. Raff, Apoptosis and bcl-2 protein in cells without mitochondrial DNA, Nature 361:365 (1993).
57. P. Monaghan, D. Robertson, T. Andrew, S. Amos, M.J.S. Dyer, D.Y. Mason and M.F. Greaves, Ultrastructural localization of bcl-2 protein, J. Histochem. Cytochem. 40:1819 (1992).
58. R. Silvestrini, S. Veneroni, M.G. Daidone, E. Benini, P. Boracchi, M. Mezzetti, G. Di Fronzo, F. Rilke and U. Veronesi, The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients, J. Natl. Cancer Inst. 86:499 (1994).
59. T. Yang, K.M. Kozopas and R.W. Craig, The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2, J. Cell Biol. 128:1173 (1995).
60. M. González-Garcia, R. Pérez-Ballestero, L. Ding, L. Duan, L.H. Boise, C.B. Thompson and G. Núñez, bcl-XL is the major bcl-X mRNA form expressed during murine development and its product localizes to mitochondria, Development 120:3033 (1994).
61. D.J. Kane, T.A. Sarafin, S. Auton, H. Hahn, F.B. Gralla, J.C. Valentine, T. Ord and D.E. Bredesen, Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species, Science 262:1274 (1993).
62. D. Hockenbery, Z. Oltvai, X.-M. Yin, C. Milliman and S.J. Korsmeyer, Bcl-2 functions in an antioxidant pathway to prevent apoptosis, Cell 75:241 (1993).
63. M.D. Jacobson and M.C. Raff, Programmed cell death and Bcl-2 protection in very low oxygen, Nature 374:814 (1995).
64. L, Nature 374:811 (1995).
65. G. Baffy, T. Miyashita, J.R. Williamson and J.C. Reed, Apoptosis induced by withdrawal of Interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production, J. Biol. Chem. 268:6511 (1993).
66. 2+ fluxes, Proc. Natl. Acad. Sci. USA 91:6569 (1994).
67. J.J. Ryan, E. Prochownik, C.A. Gottlieb, I.J. Apel, R. Merino, G. Nuñez and M.F. Clarke, c-myc and bcl-2 modulates p53 function by altering p53 subcellular trafficking during the cell cycle, Proc. Natl. Acad. Sci. USA 91:5878 (1994).
68. W. Meikrantz, S. Gisselbrecht, S.W. Tam and R. Schlegel, Activation of cyclin A-dependent protein kinases during apoptosis, Proc. Natl. Acad. Sci. USA 91:3754 (1994).
69. J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis and H.R. Horvitz, The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme, Cell 75:641 (1993).
70. A.M. Chinnaiyan, K. Orth, K. O'Rourke, H. Duan, G.G. Poirier and V.M. Dixit, Molecular odering of the cell death pathway: Bcl-2 and Bcl-XL function upstream of the CED-3-like apoptotic proteases, J. Biol. Chem. in press.:(1996).
71. C.A. Boulakia, G. Chen, F.W.H. Ng, J.G. Teodoro, P.E. Branton, D.W. Nicholson, G.G. Poirier and G.C. Shore, Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase, Oncogene 12:29 (1996).
72. H.-G. Wang, T. Miyashita, S. Takayama, T. Sato, T. Torigoe, S. Krajewski, S. Tanaka, III Hovey, L., J. Troppmair, U.R. Rapp and J.C. Reed, Apoptosis regulation by interaction of bcl-2 protein and Raf-1 kinase, Oncogene 9:2751 (1994).
73. M.J. Fernandez-Sarbia and J.R. Bischoff, Bcl-2 associates with the ras-related protein R-ras p23, Nature 366:274 (1993).
74. H.-G. Wang, J.A. Millan, A.D. Cox, C.J. Der, U.R. Rapp, T. Beck, H. Zha and J.C. Reed, R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism, J. Cell Biol. 129:1103 (1995).
75. H. Zha, C. Aime-Sempe, T. Sato and J.C. Reed, Pro-apoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2, J. Biol. Chem. in press (1996).
76. T. Sato, S. Irie, S. Krajewski and J.C. Reed, Cloning and sequencing of cDNA encoding rat bcl-2 protein, Gene 140:291 (1994).
77. M. Hanada, C. Aimé-Sempé, T. Sato and J.C. Reed, Structure-function analysis of bcl-2 protein: identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with box, J. Biol. Chem. 270:11962 (1995).
78. T. Chittenden, C. Flemington, A.B. Houghton, R.G. Ebb, G.J. Gallo, B. Elangovan, G. Chinnadurai and R.J. Lutz, A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions, EMBO J. 14:5589 (1995).
79. J.J. Hunter and T.G. Parslow, A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis, J. Biol. Chem. in press (1996).
80. C. Borner, I. Martinou, C. Mattmann, M. Irmler, E. Scharer, J.-C. Martinou and J. Tschopp, The protein bcl-2alpha does not require membrane attachment, but two conserved domains to suppress apoptosis, J. Cell Biol. 126:1059 (1994).
81. J.J. Hunter, B.L. Bond and T.G. Parslow, Functional dissection of the human Bcl-2 protein: sequence requirements for inhibition of apoptosis, Mol. Cell. Biol. in press (1996).
82. T. Subramanian, J.M. Boyd and G. Chinnadurai, Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins, Oncogene 11:2403 (1995).
83. X.M. Yin, Z.N. Oltvai and S.J. Korsmeyer, BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax, Nature 369:321 (1994).
84. S. Takayama, T. Sato, S. Krajewski, K. Kochel, S. Irie, J.A. Millan and J.C. Reed, Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity, Cell 80:279 (1995).
85. L, Nature 379:554 (1996).
86. S.V. Razin and I.I. Gromova, The channels model of nuclear matrix structure, BioEssays 17:443 (1995).